Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Mallinckrodt bags late-stage infantile jaundice drug in $425M InfaCare buyout deal
Mallinckrodt bags late-stage infantile jaundice drug in $425M InfaCare buyout deal
Mallinckrodt bags late-stage infantile jaundice drug in $425M InfaCare buyout deal
Submitted by
admin
on August 7, 2017 - 11:25am
Source:
Endpoints
News Tags:
Mallinckrodt
infantile jaundice
InfaCare
M&A
Stanate
Headline:
Mallinckrodt bags late-stage infantile jaundice drug in $425M InfaCare buyout deal
Do Not Allow Advertisers to Use My Personal information